SCHEMBL14865765

SCHEMBL14865765

CCCOCCOCC(O)CSC(C)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.42
TDP1 Q9NUW8 1/20 0.37
METAP2 P50579 3/20 0.33
METAP1 P53582 3/20 0.33
USP2 O75604 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
ALOX15 P16050 1/20 0.32
LPAR5 Q9H1C0 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865767 0.84 HSD17B10 (0.44) HSD17B10TDP1USP2CYP1A2CYP3A4
SCHEMBL14865755 0.80 ALDH1A1 (0.43) HSD17B10TDP1CYP3A4ALDH1A1ALOX15
SCHEMBL14865763 0.76 CYP1A2 (0.41) HSD17B10TDP1USP2CYP1A2CYP3A4
SCHEMBL14865760 0.75 METAP2 (0.33) METAP2METAP1
SCHEMBL10405304 0.71 HSD17B10 (0.50) HSD17B10TDP1USP2CYP1A2CYP3A4
SCHEMBL20491931 0.70 HSD17B10 (0.67) HSD17B10TDP1USP2CYP1A2CYP3A4
SCHEMBL9589743 0.70 HSD17B10 (0.50) HSD17B10TDP1METAP2METAP1USP2
SCHEMBL14865764 0.70 HSD17B10 (0.41) HSD17B10TDP1USP2CYP1A2CYP3A4
Methoxymethane SCHEMBL9268401 0.70 HSD17B10 (0.43) HSD17B10TDP1METAP2METAP1MEN1
SCHEMBL9775068 0.68 ALDH1A1 (0.42) HSD17B10TDP1METAP2METAP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C HSD17B10 2100/4885TDP1 4011/4885METAP2 4399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.